Related Experiment Videos
Lipid-lowering drugs: focus on HMG-CoA reductase inhibitors. Introduction
Atherosclerosis
|December 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections.
Infectious diseases and therapy·2022
Ibrexafungerp: A novel oral glucan synthase inhibitor.
Medical mycology·2019
Dyslipidaemia and the military patient.
Journal of the Royal Army Medical Corps·2015
Disseminated Burkholderia gladioli infection in a lung transplant recipient with underlying hypocomplementemic urticarial vasculitis.
Transplant infectious disease : an official journal of the Transplantation Society·2011
Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.
Atherosclerosis·2026
Erratum: In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways.
American journal of cancer research·2026
Case Report: Pasireotide treatment in neonatal congenital hyperinsulinism due to a homozygous ABCC8 mutation.
Frontiers in endocrinology·2026
The emerging applications of JAK inhibitors in dermatology - a systematic review.
The Journal of dermatological treatment·2026
Multi-omics analysis of glucocorticoid receptor crosstalk with Type I and Type II inflammatory signaling in human airway smooth muscle cells.
American journal of physiology. Lung cellular and molecular physiology·2026